A crew member aboard a Viking Mediterranean cruise went overboard Monday near Italy, and the Italian Coast Guard is searching ...

As stated above, Viking is a pre-revenue company, so it doesn’t give investors much to go on by way of fundamental analysis. However, the company delivered a loss per share of 81 cents, which was ...

The world's oldest president, Paul Biya, 92, was elected Cameroon's leader again, a title he's held since 1992. Young people ...

Viking Therapeutics recently initiated a Phase 1 clinical trial to evaluate various maintenance dosing regimens of VK2735, its dual GLP-1/GIP agonist, in adults with obesity after reporting positive ...

Viking Therapeutics stock popped Thursday on the lightning pace it's enrolling patients in a pair of obesity treatment tests.

In common with many other small-cap biotech stocks, Viking Therapeutics ' ( VKTX +8.47%) share price tends to be volatile as ...

Not many teams have found success stopping Jalen Hurts and the Eagles in short yardage situations. Here's how the Vikings attempted to stop the "Tush Push." ...

Since then, supply has returned thanks to Lilly's investments in manufacturing and a move to also offer Zepbound, previously ...

Shares of Viking Therapeutics experienced significant upward momentum, climbing 8.1% to reach $33.90 amid renewed market speculation about potential acquisition activity in the obesity treatment ...

Across the recent three months, 10 analysts have shared their insights on Viking Holdings (NYSE: VIK ), expressing a variety of opinions spanning from bullish to bearish. In the table below, you'll ...

Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.

Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best biotech stocks with high potential. H.C. Wainwright analyst Joseph Pantginis reiterated a bullish stance on Viking Therapeutics, Inc. (NASDAQ ...